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SUMMARY
The Nucleosome Remodeling and Deacetylase (NuRD) complex is a chromatin regulatory complex that functions as a transcriptional co-
repressor in metazoans. The NuRD subunit MBD3 is essential for targeting and assembly of a functional NuRD complex as well as em-
bryonic stem cell (ESC) pluripotency. Three MBD3 isoforms (MBD3A, MBD3B, and MBD3C) are expressed in mouse. Here, we find
that the MBD3C isoform contains a unique 50-amino-acid N-terminal region that is necessary for MBD3C to specifically interact with
the histone H3 binding protein WDR5. Domain analyses of WDR5 reveal that the H3 binding pocket is required for interaction with
MBD3C. We find that whileMbd3c knockout ESCs differentiate normally, MBD3C is redundant with the MBD3A and MBD3B isoforms
in regulation of gene expression, with the unique MBD3C N terminus required for this redundancy. Together, our data characterize a
unique NuRD complex variant that functions specifically in ESCs.
INTRODUCTION
To maintain their cellular identity, embryonic stem cells
(ESCs) utilize a network of core transcription factors and
chromatin remodeling enzymes that bind and regulate plu-
ripotency genes and differentiation genes in response to
developmental signaling (Kim et al., 2008). The Nucleo-
some Remodeling and Deacetylase (NuRD) complex is
unique among chromatin regulators because it couples
ATP-dependent nucleosome remodeling activity with
histone modification (deacetylase) activity (Tong et al.,
1998; Wade et al., 1998; Xue et al., 1998; Zhang et al.,
1998). NuRD alters nucleosome occupancy to block the
binding of transcriptional machinery at gene promoters,
thus functioning primarily as a co-repressor (Denslow
and Wade, 2007; Yildirim et al., 2011). In addition, mice
deleted for theMbd3 gene, which encodes a NuRD subunit
important for NuRD targeting and assembly, are nonviable
(Hendrich et al., 2001). ESCs derived from Mbd3-null
mouse embryos do not differentiate and are capable of
self-renewal in culture in the absence of leukemia inhibi-
tory factor (LIF) (Kaji et al., 2006). Mbd3 was subsequently
shown to be important for differentiation and develop-
ment through silencing of pluripotency genes (Reynolds
et al., 2012), functioning in part by deacetylation of
H3K27 (Reynolds et al., 2011).
MBD3 was originally identified as a member of the
methyl-CpG binding domain (MBD) family of proteins
(Hendrich and Bird, 1998). However, unlikeMBDmembers
MECP2 and MBD1, 2, and 4, MBD3 does not bind methyl-
ated DNA (Hendrich and Bird, 1998; Zhang et al., 1999).
Three MBD3 isoforms (MBD3A, B, and C) are expressed
in mouse ESCs, and only MBD3A has a full-length MBD
(Kaji et al., 2006). Thus, the possibility exists for formation
of multiple NuRD complexes of varying subunit combina-
tions and functional specificities.
Here, we have characterized a unique variant of
the NuRD chromatin remodeling complex that harbors
MBD3C, an ESC-specific isoform of MBD3, as well as the
histone H3 binding protein WDR5. MBD3C is expressed
almost exclusively in ESCs via an alternative CpG island
(CGI)-containing promoter located in the second intron
of the Mbd3 gene. We further show that MBD3C contains
a unique 50-amino-acid N terminus that is necessary for
WDR5 interaction. MBD3C interacts with the WDR5 H3
binding pocket through an arginine-containing motif
also utilized by MLL1 for WDR5 binding. RNA sequencing
(RNA-seq) analysis revealed that the three MBD3 isoforms
are largely redundant for gene regulation, since knockout
(KO) of all three isoforms had a more severe effect on
gene expression than individual KO of Mbd3c or simulta-
neous KO of Mbd3a and Mbd3b. Importantly, the WDR5-
interaction domain of Mbd3c is critical for its gene regula-
tory function, suggesting that WDR5 plays critical roles
in MBD3C/NuRD complex.
RESULTS AND DISCUSSION
MBD3C/NuRD Co-purifies with WDR5
To identify proteins co-purifying with MBD3 in ESCs, we
used a cell line in which one copy of endogenous MBD3
1488 Stem Cell Reports j Vol. 8 j 1488–1496 j June 6, 2017 j ª 2017 The Author(s).
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
is fused to a C-terminal 6xHis-3xFLAG tag (Mbd3-H3F;
Yildirim et al., 2011), allowing for affinity purification of
MBD3A, B, and C simultaneously (Figures 1A and S1A).
Liquid chromatography-tandem mass spectrometry (LC-
MS/MS) of purified MBD3 complexes identified all canoni-
cal NuRD subunits, several of which were subsequently
confirmed by western blot (Figure 1B and Table S1).
Consistent with recent MS analyses of NuRD compo-
nents (Bode et al., 2016), we detected an interaction be-
tween MBD3 and the SET/MLL complex component
WDR5 (Figures 1B and S1B; Table S1). The MLL complex
is a histone methyltransferase that catalyzes methylation
of H3K4, a mark found at transcriptionally active genes
(Bernstein et al., 2002; Santos-Rosa et al., 2002). WDR5
binds the histone H3 tail in vitro and is essential
for H3K4 trimethylation and MLL complex formation
(Couture et al., 2006; Dou et al., 2006; Ruthenburg et al.,
2006; Schuetz et al., 2006; Wysocka et al., 2005). We did
not observe any other MLL subunits co-purifying with
MBD3 (Figure 1B and Table S1), suggesting that WDR5 in-
teracts with MBD3/NuRD independently of MLL complex.
To validate these data, we performed co-immunoprecipita-
tion (coIP) assays. Interestingly, WDR5 immunoprecipita-
tion pulled down MBD3C, but not the more abundant
isoforms, MBD3A and B (Figure 1C). These data suggest
that WDR5 interacts specifically with this smallest and
least characterized isoform of MBD3.
To further investigate the composition of the MBD3C/
NuRD complex, we generated an ESC line expressing
Mbd3c-H3F from a viral vector, such that only the
MBD3C isoform is epitope-tagged. To this end, we first per-
formed 50 rapid amplification of cDNA ends (50-RACE)
to obtain the Mbd3c coding sequence. We found that
MBD3C is translated from a start codon within intron 2
of theMbd3 gene, consistent with a recent report (dos San-
tos et al., 2014). Thus, MBD3C lacks the entire MBD and
contains a unique 50-amino-acid N terminus (Figure S1C).
MBD3C-H3F complexes were affinity purified (Figure 1D)
and analyzed by LC-MS/MS. As expected, WDR5 co-pu-
rifies with MBD3C-H3F but not MBD3A-H3F (Figures 1E
and S1D; Table S2). Importantly, we found that WDR5
interaction was disrupted by deletion of the unique
Figure 1. The NuRD Subunit MBD3C Co-
purifies with WDR5
(A) Silver stain of MBD3-H3F complex.
(B) Western blot (WB) of purified complex
from (A) showing interaction of MBD3 with
NuRD subunits (left) and with WDR5 or MLL
subunit ASH2L (right).
(C) Western blots for MBD3-H3F or WDR5
upon immunoprecipitation (IP) of each.
Asterisk indicates immunoglobulin G (IgG).
(D) Silver stain of MBD3 complex expressing
individually H3F-tagged MBD3 isoforms.
(E) Western blot of purified complexes from
(D) showing interaction with WDR5 and
NuRD subunits.
(F) WDR5 or FLAG immunoprecipitation
from individually tagged MBD3C-H3F and
MBD3CDN-H3F ESCs. Asterisks indicate IgG.
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MBD3C N terminus (MBD3CDN; Figures 1E and S1D),
demonstrating that this domain is necessary for WDR5
binding. CoIP experiments confirmed these results (Fig-
ure 1F). Furthermore, we observed that MBD3C-H3F,
MBD3A-H3F, andMBD3CDN-H3F all co-purify with the ca-
nonical NuRD subunits (Figures 1E and S1D; Table S2).
Together with data showing that WDR5 also co-purifies
with NuRD subunits (Figure S1B; Bode et al., 2016) and
that MBD3C co-fractionates exclusively with NuRD
subunit MTA1 (Figure S1E), these data demonstrate that
MBD3C assembles into a canonical NuRD complex that
also includes WDR5. Although the MBD3 MBD was previ-
ously shown to directly interact with NuRD subunits
HDAC1 and MTA2 in vitro (Saito and Ishikawa, 2002),
our findings suggest that HDAC1 and MTA2 can also asso-
ciate with the NuRD complex byMBD-independent mech-
anisms in vivo. In addition, while the unique MBD3C
N terminus is required for interaction with WDR5, it is
dispensable for interaction with the other known NuRD
subunits (Figure S1D and Table S2).
The WDR5 Histone H3 Binding Pocket Is Required for
Interaction with MBD3C
To gain insight into the functions of the MBD3C-WDR5
interaction, we dissected the domains within MBD3C
andWDR5 important for their interaction.WDR5 contains
two binding surfaces on opposite sides of the protein, one
that binds the histone H3 N-terminal tail or the SET/MLL
complex subunit MLL1, and another that binds both the
SET/MLL subunit RBBP5 (Figure 2A;Odho et al., 2010; Patel
et al., 2008; Song and Kingston, 2008) and long noncoding
RNAs (Yang et al., 2014). To test whether MBD3C interacts
with either WDR5 binding surface, we performed coIPs in
293T cells co-transfected with vectors expressing MBD3C-
H3F and FLAG-tagged point mutants from both binding
surfaces of WDR5: D107A on the H3K4/MLL1 binding sur-
face and F266A, K250A, and R181A on the RBBP5/RNA
binding surface (Yang et al., 2014). We found that the
F266A, K250A, and R181A mutants of WDR5 co-immuno-
precipitate with antibodies recognizing endogenousMBD3
(Figure 2B). In contrast, theD107Amutantwas absent from
MBD3 immunoprecipitates, suggesting that MBD3C binds
near or within the WDR5 H3K4/MLL1 binding pocket.
To extend these findings, we generated a series of trunca-
tion mutants of the 50-amino-acid MBD3C N terminus to
pinpoint the residues necessary for binding (Figure 2C).
Deletion of the first 40 amino acids of H3F-tagged
MBD3C did not disrupt the interaction with V5-tagged
WDR5 (Figure 2D). However, upon deletion of amino acids
41–50 of MBD3C, interaction with WDR5 was completely
lost (Figure 2E), as we observed for MBD3C mutants lack-
ing amino acids 1–50 (Figures 1E, 1F, and 2D). Further-
more, an N-terminal fusion of amino acids 41–50 to the
MBD3A isoform was sufficient to allow MBD3A to bind
WDR5 (Figure 2F). These data demonstrate that amino
acids 41–50 of MBD3C mediate WDR5 binding (see also
Figure S1B).
MLL1, KANSL1, and histone H3 all bind the same
domain on WDR5 via a 2-amino-acid alanine-arginine
(AR) motif present on each protein (Couture et al., 2006;
Han et al., 2006; Patel et al., 2008; Ruthenburg et al.,
2006; Schuetz et al., 2006; Song and Kingston, 2008; Dias
et al., 2014; Figures 2A and 2G). MBD3C contains an AR
dipeptide within its N-terminal WDR5 binding domain
(A42-R43; Figure 2G), which we hypothesized to be neces-
sary for WDR5 binding. Confirming our hypothesis, an
R43A mutant of MBD3C failed to pull down WDR5 (Fig-
ure 2E). Together, these data indicate that MBD3C, histone
H3, and MLL1 use a common motif to bind the same
surface of WDR5. We observed slightly reduced MBD3C
protein levels in cells expressing mutants of MBD3C or
WDR5 that disrupt MBD3C-WDR5 binding (Figures 2D
and 2E), raising the possibility that interaction with
WDR5 plays a role in stabilizing MBD3C.
Mbd3c Expression Is Largely Restricted to Pluripotent
Stem Cells
The Mbd3c isoform appears to be highly expressed only in
ESCs, as it is absent or weakly expressed in mouse embry-
onic fibroblasts (MEFs) and all adult tissues tested (Figures
S1A and S2A). To determine when Mbd3c expression is
lost during differentiation, we subjected ESCs to a 10-day
embryoid body (EB) differentiation time course. We
observed that MBD3C protein was lost between days 4
and 6 of the time course with kinetics similar to loss of
OCT4 protein during differentiation (Figure 3A).
Next, we tested whether Mbd3c expression was restored
upon reprogramming of differentiated cells to induced
pluripotent stem cells. Primary MEFs were infected with
doxycycline (dox)-inducible lentiviruses expressing re-
programming factors OCT4, SOX2, and KLF4 marked
with an mCherry reporter (OSK-mCherry), L-MYC, and
a lentiviral EOS-EGFP reporter specifically activated in
pluripotent cells (Hotta et al., 2009). Infected cells were
cultured with dox for 20 days. After an additional 10 days
in the absence of dox, cells were imaged and stained for
alkaline phosphatase to verify silencing of OSK-mCherry
and presence of ESC-like colonies (Figures S3A and S3B).
Lysates for western blots were prepared from expanded
induced pluripotent stem cell (iPSC) colonies picked at
30 days.We observed that reprogrammed iPSC colonies ex-
press Mbd3c (Figure 3B). These data demonstrate that
Mbd3c expression is restored when somatic cells are reprog-
rammed to iPSCs.
Finally, to investigate how Mbd3c expression might be
silenced during differentiation, we performed bisulfite
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pyrosequencing analysis on the Mbd3c promoter during
an EB differentiation time course. The Mbd3 gene con-
tains a 350-bp CGI which spans exon 2 and part of
intron 2, and overlaps with the sequence encoding the
MBD3C N-terminal domain (Figure 3C). We measured
methylation of 11 individual CpGs within the Mbd3c
promoter and observed a large increase in methylation
at all sites over the differentiation time course (Fig-
ure 3D). Methylation increased most dramatically
around day 4, which corresponds to the timing of
MBD3C loss during differentiation (Figure 3A). There-
fore, silencing ofMbd3c expression during differentiation
is likely due to increased methylation of the Mbd3c pro-
moter CGI.
Figure 2. The WDR5 Histone H3 Binding Pocket Is Required to Bind MBD3C
(A) PyMol depiction of WDR5 crystal structure (PDB: 2GNQ) showing the H3K4/MLL1 (left) and RBBP5 (right) binding pockets. Residues
individually mutated to alanine (Yang et al., 2014) are shown in magenta. Residues necessary for MLL1 R3761 or histone H3 R2 binding are
shown in orange.
(B) CoIPs with MBD3 antibody from 293T cells co-transfected with expression vectors carrying MBD3C-H3F and indicated FLAG-tagged
WDR5 mutants.
(C) Schematic of Mbd3c N-terminal mutant constructs used in (D) and (E).
(D–F) CoIPs with MBD3 antibody in 293T cells performed as in (B), using V5-tagged WDR5 constructs and H3F-tagged MBD3 constructs. For
‘‘C41-50MBD3A,’’ MBD3C amino acids 41–50 were fused to the N terminus of the MBD3A isoform.
(G) Alignment of the MBD3C N terminus with WDR5-binding regions of mouse MLL1, KANSL1, and histone H3.
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Mbd3c Is Dispensable for ESC Differentiation
Mbd3-null ESCs exhibit pluripotency defects and are
capable of self-renewal in the absence of LIF (Kaji et al.,
2006). We therefore wanted to test whether the
MBD3C isoform was specifically required for early stages
of differentiation. We generated homozygous Mbd3c,
Mbd3ab, and Mbd3abc KO ESCs (Figure S2B) using
CRISPR/Cas9 cleavage and error-prone DNA repair
(Cong et al., 2013). We found that Mbd3c KO ESCs pro-
liferate similarly to wild-type (WT) cells. In contrast,
Mbd3ab KO and especially Mbd3abc KO ESCs grow
more slowly than WT (Figures S2C and S2D), consistent
with previous observations of Mbd3-null ESCs (Kaji
et al., 2006).
Next, we tested the differentiation capacity of each
Mbd3 mutant. Consistent with previous studies (Kaji
et al., 2006), we found that ESCs lacking all MBD3 iso-
forms (Mbd3abc KO) maintained expression of both
OCT4 and NANOG over 9 days in medium without LIF
(Figure 3E). Unlike Mbd3abc KOs, Mbd3c KOs did not
show a noticeable differentiation defect (Figure 3F). ESCs
expressing onlyMbd3c (Mbd3ab KO) were largely defective
in differentiation (although OCT4 and NANOG levels
appeared slightly reduced relative to Mbd3abc KO lines).
Since Mbd3c expression is lost early during differentiation
(Figures 3A and 3E), Mbd3ab mutants are functionally
equivalent to Mbd3abc mutants at mid- to late-differ-
entiation time points, potentially accounting for this
Figure 3. Mbd3c Is Dispensable for ESC
Differentiation
(A) Western blots from ESCs differentiated
over 10 days. Actin serves as a loading
control.
(B) Western blots from primary MEFs re-
programmed to iPSCs.
(C) Schematic of theMbd3 gene showing the
sequence and location of the Mbd3c pro-
moter CpG island (red bar). Light-blue boxes
indicate exons. CpGs tested for methylation
are highlighted in red.
(D) Pyrosequencing of bisulfite-converted
DNA from cells collected at the indicated
differentiation time points. Error bars repre-
sent the SD of three biological replicates.
(E and F) Western blots of differentiating
Mbd3ab and Mbd3abc KO cells (E) and two
clonal Mbd3c KO lines (F). WT, wild-type.
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phenotype. We next asked whether constitutive over-
expression of Mbd3c in the absence of MBD3A and
MBD3B could allow for normal differentiation. To test
this possibility, we replaced the entire Mbd3 gene with
an H3F-tagged Mbd3c transgene overexpressed from the
CAG promoter, which is not silenced during differentia-
tion. Differentiation proceeds normally in these cells (Fig-
ure S2E, top panel), revealing that MBD3C can compen-
sate for MBD3A and MBD3B when it is overexpressed.
Unexpectedly, ESCs overexpressing Mbd3cDN were also
able to differentiate (Figure S2E, bottom panel), in marked
contrast to cells expressingMbd3cDN at endogenous levels
(Figure S2F). We conclude that Mbd3c is not required for
differentiation but can substitute for Mbd3a and Mbd3b
when overexpressed.
MBD3 Isoforms Function Redundantly in Gene
Regulation
Although it is dispensable for differentiation, MBD3C
binds chromatin (Figure S4) and could still be important
for regulation of a subset of MBD3 target genes indepen-
dently of the other MBD3 isoforms. To test this possibility,
we analyzed the transcriptomes of Mbd3 isoform-specific
mutant ESCs by RNA-seq. Gene expression in Mbd3c
KO ESCs was largely normal (Figure 4A, left panel), with
expression of only 38 genes changed more than 2-fold
Figure 4. MBD3C Is Redundant with MBD3A and MBD3B in Regulation of Gene Expression
(A and B) MA plots showing log2 (fold change) in gene expression in Mbd3c KO (A, left), Mbd3ab KO (A, right), Mbd3abc KO (B, left), and
Mbd3cDN-ab KO (B, right) ESCs relative to wild-type (WT). Genes shown are misregulatedR2-fold compared with WT.
(C and D) Venn diagrams showing overlap between misregulated genes in ESCs of indicated genotypes.
(E and F) WDR5 binding (Ang et al., 2011) (E) and MOF binding (Li et al., 2012) (F) averaged over transcription start sites (TSS) of
misregulated or unchanged genes in Mbd3abc KO (red) and Mbd3cDN-ab KO ESCs (purple).
(G) Average WDR5 binding over MBD3-bound (Yildirim et al., 2011), TSS-distal DNase I hypersensitive sites (DHSs) (GSM1014514).
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compared with WT. Similarly, we observed relatively few
genes (258) misregulated in Mbd3ab KO ESCs that express
only Mbd3c (Figure 4A, right panel) compared with a
much larger number (4,879) misregulated in ESCs where
all Mbd3 isoforms are deleted (Figures 4B [left panel] and
4C). These data suggest thatMbd3c can largely compensate
for the loss of Mbd3a and Mbd3b at shared target genes.
To test whether the unique 50-amino-acid MBD3CN ter-
minus (and thus the interaction with WDR5) is important
for this compensatory effect, we also performed RNA-seq
on ESCs lacking MBD3A and MBD3B and the N terminus
of MBD3C (Mbd3cDN-ab KO). In contrast to the relatively
few genes misregulated inMbd3ab KO andMbd3c KO cells,
we observed 2,431 genes misregulated in Mbd3cDN-ab
KO cells, with nearly twice as many genes upregulated as
downregulated (1,577 versus 854, respectively; Figure 4B,
right panel). The vast majority (93%) of misregulated
genes overlapped with genes misregulated in Mbd3abc KO
cells (Figure 4D), indicating that the MBD3C N terminus
is largely required for MBD3C to compensate for loss of
MBD3A andMBD3B. However, asMbd3abc KO has a stron-
ger phenotype than Mbd3cDN-ab KO, MBD3C/NuRD may
also regulate some genes independently of its N-terminal
domain. Closer examination of the 2,627 genes misregu-
lated only inMbd3abcKOESCs (Figure 4D) revealed similar,
but weaker misregulation in Mbd3cDN-ab KO cells in
most cases that fell below our 2-fold cutoff. These data
suggest that the Mbd3cDN mutation is not a complete
null and are consistent with our finding that MBD3CDN
can compensate for loss of MBD3A and MBD3B during
ESC differentiation, but only when overexpressed (Figures
S2E and S2F).
WDR5 is a component of multiple complexes with key
regulatory functions in ESCs (Ang et al., 2011; Li et al.,
2012).Wdr5 knockdown results in loss of ESC self-renewal
(Ang et al., 2011), precluding the use of Wdr5 KO ESCs to
compare the functions of MBD3C andWDR5 in gene regu-
lation. However, to test whether the genes misregulated in
Mbd3c mutant cells are targets of WDR5 and/or WDR5-
associated complexes, we examined published ESC chro-
matin immunoprecipitation sequencing data for WDR5
and the MSL/NSL subunit MOF (Ang et al., 2011; Li et al.,
2012). We observed considerably higher WDR5 binding
at the promoter-proximal regions of genes that were
misregulated in Mbd3abc KO and Mbd3cDN-ab KO cells
compared with genes that were unaffected byMbd3muta-
tions (Figure 4E), consistent with a regulatory role for
WDR5 at MBD3 target genes. However, it is likely that
WDR5 regulates some of these genes through mechanisms
independent of MBD3C/NuRD, as we also observed higher
MOF binding at genes misregulated in Mbd3abc KO
and Mbd3cDN-ab KO cells (Figure 4F). Similarly, we
found that WDR5 binding is enriched at promoter-distal
DNase I hypersensitive sites that are co-bound by MBD3
(Figure 4G), suggesting that WDR5 and MBD3 co-regulate
target gene expression at both promoter-distal enhancers
and promoters.
We have identified a variant ESC-specific NuRD com-
plex that includes the histone H3 binding protein
WDR5. While WDR5 contributes to H3K4 trimethlyation
by the SET/MLL complex (Ang et al., 2011; Yang et al.,
2014) our data suggest that a WDR5-binding MBD3C/
NuRD complex functions separately from SET/MLL.
Consistent with these findings, we showed that MBD3C
interacts with WDR5 at the same binding surface as
MLL1 and histone H3, using a conserved arginine-con-
taining motif (Couture et al., 2006; Patel et al., 2008). As
MBD3/NuRD has previously been shown to repress plurip-
otency genes during differentiation (Reynolds et al.,
2012), it is possible that MBD3C/NuRD functions to
oppose SET/MLL activity.
Our data reveal an additional layer of complexity to the
composition and function of chromatin remodelers in
ESCs and uncover a previously unidentified function for
the WDR5 protein. The WDR5 binding domain appears
to be essential for MBD3C/NuRD function in ESCs, while
other MBD3/NuRD complexes are recruited to the same
target genes via the MBD or other binding domains. How-
ever, since the differentiation defect ofMbd3abKO cells can
be overcome by constitutive overexpression of Mbd3cDN,
WDR5 may simply enhance the chromatin binding or re-
modeling activities of MBD3C/NuRD. Multiple indepen-
dent mechanisms likely target different NuRD complexes
to overlapping targets on chromatin, where the complexes
function redundantly.
EXPERIMENTAL PROCEDURES
MBD3 Purification and LC-MS/MS
MBD3/NuRD complex was purified from indicated H3F-tagged
ESCs as described by Yildirim et al. (2011). Purified samples were
separated by SDS-PAGE, and LC-MS/MS was performed as
described by Chen et al. (2013).
Embryoid Body Differentiation
ESCs were differentiated to EBs in suspension culture. Cells (2.5 3
106) were plated in ESC medium without LIF in bacteriological
plates. Cells were replated to nongelatinized cell culture plates after
3 days and harvested for western blots at the indicated time points.
RNA-Seq
Total RNA was isolated from WT and mutant ESCs using TRIzol
(Life Technologies), and purified with the Zymo RNA Clean
and Concentrator kit. Strand-specific libraries were prepared
and sequenced by Applied Biological Materials, and analyzed as
described in Supplemental Experimental Procedures.
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